Angiosarcoma Following Radiation Therapy for Breast Cancer:Case Presentation and Clinical Management Considerations

Joseph R. Scalea, Branko Bojovic, Robin Legros, Julia Choi, Andrea Hebert, Nader Hanna

.
Division of General & Oncologic Surgery, University of Maryland School of Medicine, Baltimore, USA.

DOI: 10.4236/ojpathology.2013.34033                

Abstract

A 59-year-old woman presented with erythema and pruritis of the breast 4.5 years after undergoing lumpectomy and radiation for breast cancer. Biopsy confirmed a diagnosis of angiosarcoma. This tumor stained positive for CD34 as well as 70% Ki67 prior to therapy initiation. A multidisciplinary approach yielded a plan for neoadjuvant chemoradiation and surgical resection including delayed completion transverse rectus abdominis flap for tissue coverage. Neoadjuvant therapy successfully decreased rates of cellular proliferation, as reflected by a Ki67 of 5%, at the time of resection. Pathophysiologically, angiosarcomas may be very aggressive and may develop following radiation for breast cancer. Such tumors may become more common as breast cancer therapies, which frequently include radiation therapy, improve with time. Early recognition of angiosarcoma is imperative for successful therapy. These tumors may present with a wide range of symptoms, but may be asymptomatic. Surgical resection is the preferred therapy, but early recognition is critical.

Keywords

Angiosarcoma; Breast Cancer; Radiation Therapy; Immunohistochemistry; TRAM Flap

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	R. J. Young, N. J. Brown, M. W. Reed, D. Hughes and P. J. Woll, “Angiosarcoma,” Lancet Oncology, Vol. 11, No. 10, 2010, pp. 983-991. http://dx.doi.org/10.1016/S1470-2045(10)70023-1
[2]	M. G. Fury, C. R. Antonescu, K. J. Van Zee, M. F. Brennan and R. G. Maki, “A 14-Year Retrospective Review of Angiosarcoma: Clinical Characteristics, Prognostic Factors, and Treatment Outcomes with Surgery and Chemotherapy,” Cancer Journal, Vol. 11, No. 3, 2005, pp. 241-247. http://dx.doi.org/10.1097/00130404-200505000-00011
[3]	C. Leowardi, U. Hinz, Y. Hormann, M. N. Wente, G. Mechtersheimer, F. Willeke, et al., “Malignant Vascular Tumors: Clinical Presentation, Surgical Therapy, and Long-Term Prognosis,” Annals of Surgical Oncology, Vol. 12, No. 12, 2005, pp. 1090-1101. http://dx.doi.org/10.1245/ASO.2005.09.002
[4]	J. R. Toro, L. B. Travis, H. J. Wu, K. Zhu, C. D. M. Fletcher and S. S. Devesa, “Incidence Patterns of Soft Tissue Sarcomas, Regardless of Primary Site, in the Surveillance, Epidemiology, and End Results Program, 1978-2001: An Analysis of 26,758 Cases,” International Journal of Cancer, Vol. 119, No. 12, 2006, pp. 2922-2930. http://dx.doi.org/10.1002/ijc.22239
[5]	P. Rouhani, D. M. C. Fletcher, S. S. Devesa and J. R. Toro, “Cutaneous Soft Tissue Sarcoma Incidence Patterns in the U.S.: An Analysis of 12,144 Cases,” Cancer, Vol. 113, No. 3, 2008, pp. 616-627. http://dx.doi.org/10.1002/cncr.23571
[6]	J. Fayette, E. Martin, S. Piperno-Neumann, A. Le Cesne, C. Robert, S. Bonvalot, et al., “Angiosarcomas, a Heterogenous Group of Sarcomas with Specific Behaviors Depending on Primary Site: A Retrospective Study of 161 Cases,” Annals of Oncology, Vol. 18, No. 12, 2007, pp. 2030-2036. http://dx.doi.org/10.1093/annonc/mdm381
[7]	J. A. Abraham, F. J. Hornicek, A. M. Kaufman, D. C. Harmon, D. S. Springfield, K. A. Raskin, et al., “Treatment and Outcome of 82 Patients with Angiosarcoma,” Annals of Surgical Oncology, Vol. 14, No. 6, 2007, pp. 1953-1967. http://dx.doi.org/10.1245/s10434-006-9335-y
[8]	S. T. Schindera, M. Streit, U. Kaelin, E. Stauffer, L. Steinbach and S. E. Anderson, “Stewart-Treves Syndrome: MR Imaging of a Postmastectomy Upper-Limb Chronic Lymphedema with Angiosarcoma,” Skeletal Radiology, Vol. 34, No. 3, 2005, pp. 156-160. http://dx.doi.org/10.1007/s00256-004-0807-5
[9]	A. Abu-Zaid and S. Mohammed, “Primary Pleural Angiosarcoma in a 63-Year-Old Gentleman,” Case Reports in Pulmonology, Vol. 2013, 2013, Article ID: 974567.
[10]	I. W. Mattoch, J. B. Robbins, R. L. Kempson and S. Kohler, “Post-Radiotherapy Vascular Proliferations in Mammary Skin: A Clinicopathologic Study of 11 Cases,” Journal of the American Academy of Dermatology, Vol. 57, No. 1, 2007, pp. 126-133. http://dx.doi.org/10.1016/j.jaad.2006.10.025
[11]	C. Gengler, J. M. Coindre, A. Leroux, M. Trassard, D. Ranchère-Vince, I. Valo, J. J. Michels and L. Guillou, “Vascular Proliferations of the Skin after Radiation Therapy for Breast Cancer: Clinicopathologic Analysis of a Series in Favor of a Benign Process: A Study from the French Sarcoma Group,” Cancer, Vol. 109, No. 8, 2007, pp. 1584-1598. http://dx.doi.org/10.1002/cncr.22586
[12]	K. T. Patton, A. T. Deyrup and S. W. Weiss, “Atypical Vascular Lesions after Surgery and Radiation of the Breast: A Clinicopathologic Study of 32 Cases Analyzing Histologic Heterogeneity and Association with Angiosarcoma,” American Journal of Surgical Pathology, Vol. 32, No. 6, 2008, pp. 943-950. http://dx.doi.org/10.1097/PAS.0b013e31815bf8fe
[13]	G. Lahat, A. R. Dhuka, H. Hallevi, L. Xiao, C. Zou, K. D. Smith, et al., “Angiosarcoma: Clinical and Molecular Insights,” Annals of Surgery, Vol. 251, No. 6, 2010, pp. 1098-1106. http://dx.doi.org/10.1097/SLA.0b013e3181dbb75a
[14]	Y. T. Joo, C. Y. Jeong, E. J. Jung, Y. J. Lee, S. C. Hong, S. K. Choi, et al., “Intra-Abdominal Angiosarcoma Developing in a Capsule of a Foreign Body: Report of a Case with Associated Hemorrhagic Diathesis,” World Journal of Surgical Oncology, Vol. 3, 2005, p. 60. http://dx.doi.org/10.1186/1477-7819-3-60
[15]	S. Fineberg and P. P. Rosen, “Cutaneous Angiosarcoma and Atypical Vascular Lesions of the Skin and Breast after Radiation Therapy for Breast Carcinoma,” American Journal of Clinical Pathology, Vol. 102, No. 6, 1994, pp. 757-763.
[16]	Y. Toiyama, Y. Inoue, S. Saigusa, Y. Okugawa, T. Yokoe, K. Tanaka, C. Miki and M. Kusunoki, “Gene Expression Profiles of Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1 with Special Reference to Local Responsiveness to Neoadjuvant Chemoradiotherapy and Disease Recurrence after Rectal Cancer Surgery,” Clinical Oncology (Royal College of Radiologists), Vol. 22, No. 4, 2010, pp. 272- 280. http://dx.doi.org/10.1016/j.clon.2010.01.001
[17]	M. Senoo, Y. Matsumura and S. Habu, “TAp63gamma (p51A) and dNp63alpha (p73L), Two Major Isoforms of the p63 Gene, Exert Opposite Effects on the Vascular Endothelial Growth Factor (VEGF) Gene Expression,” Oncogene, Vol. 21, No. 16, 2002, pp. 2455-2465. http://dx.doi.org/10.1038/sj.onc.1205330
[18]	M. E. Kallen, F. G. Nunes Rosado, A. L. Gonzalez, M. E. Sanders and J. M. Cates, “Occasional Staining for p63 in Malignant Vascular Tumors: A Potential Diagnostic Pitfall,” Pathology & Oncology Research, Vol. 18, No. 1, 2012, pp. 97-100. http://dx.doi.org/10.1007/s12253-011-9426-3